Table of Contents
Chapter 1. Global Epigenetics Diagnostics Market Executive Summary
1.1. Global Epigenetics Diagnostics Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Application
1.3.3. By Technology
1.3.4. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Epigenetics Diagnostics Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Epigenetics Diagnostics Market Dynamics
3.1. Market Drivers
3.1.1. Escalating Prevalence of Chronic Diseases
3.1.2. Rising Advancements in Technology
3.2. Market Challenges
3.2.1. High Complexity of Interpreting Epigenetic Data
3.3. Market Opportunities
3.3.1. Growing Awareness of Personalized Medicine
3.3.2. High Strategic Collaborations
Chapter 4. Global Epigenetics Diagnostics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Epigenetics Diagnostics Market Size & Forecasts by Product 2022-2032
5.1. Segment Dashboard
5.2. Global Epigenetics Diagnostics Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Enzymes
5.2.2. Instruments and Consumables
5.2.3. Kits
5.2.4. Reagents
Chapter 6. Global Epigenetics Diagnostics Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Epigenetics Diagnostics Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Oncology
6.2.2. Metabolic Diseases
6.2.3. Developmental Biology
6.2.4. Immunology
6.2.5. Cardiovascular Diseases
6.2.6. Others
Chapter 7. Global Epigenetics Diagnostics Market Size & Forecasts by Technology 2022-2032
7.1. Segment Dashboard
7.2. Global Epigenetics Diagnostics Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. DNA Methylation
7.2.2. Histone Methylation
7.2.3. Others
Chapter 8. Global Epigenetics Diagnostics Market Size & Forecasts by End User 2022-2032
8.1. Segment Dashboard
8.2. Global Epigenetics Diagnostics Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Academic and Research Institutes
8.2.2. Pharmaceutical Companies and Biotechnology Companies
8.2.3. Contract Research Organizations (CROs)
Chapter 9. Global Epigenetics Diagnostics Market Size & Forecasts by Region 2022-2032
9.1. North America Epigenetics Diagnostics Market
9.1.1. U.S. Epigenetics Diagnostics Market
9.1.1.1. Product breakdown size & forecasts, 2022-2032
9.1.1.2. Application breakdown size & forecasts, 2022-2032
9.1.1.3. Technology breakdown size & forecasts, 2022-2032
9.1.1.4. End User breakdown size & forecasts, 2022-2032
9.1.2. Canada Epigenetics Diagnostics Market
9.2. Europe Epigenetics Diagnostics Market
9.2.1. U.K. Epigenetics Diagnostics Market
9.2.2. Germany Epigenetics Diagnostics Market
9.2.3. France Epigenetics Diagnostics Market
9.2.4. Spain Epigenetics Diagnostics Market
9.2.5. Italy Epigenetics Diagnostics Market
9.2.6. Rest of Europe Epigenetics Diagnostics Market
9.3. Asia-Pacific Epigenetics Diagnostics Market
9.3.1. China Epigenetics Diagnostics Market
9.3.2. India Epigenetics Diagnostics Market
9.3.3. Japan Epigenetics Diagnostics Market
9.3.4. Australia Epigenetics Diagnostics Market
9.3.5. South Korea Epigenetics Diagnostics Market
9.3.6. Rest of Asia Pacific Epigenetics Diagnostics Market
9.4. Latin America Epigenetics Diagnostics Market
9.4.1. Brazil Epigenetics Diagnostics Market
9.4.2. Mexico Epigenetics Diagnostics Market
9.4.3. Rest of Latin America Epigenetics Diagnostics Market
9.5. Middle East & Africa Epigenetics Diagnostics Market
9.5.1. Saudi Arabia Epigenetics Diagnostics Market
9.5.2. South Africa Epigenetics Diagnostics Market
9.5.3. Rest of Middle East & Africa Epigenetics Diagnostics Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Bio-Techne
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Promega Corporation
10.3.3. GeneTex, Inc.
10.3.4. PacBio
10.3.5. Illumina, Inc.
10.3.6. Merck KGaA
10.3.7. QIAGEN
10.3.8. F. Hoffmann-La Roche Ltd
10.3.9. Eisai Co., Ltd.
10.3.10. Novartis AG
10.3.11. Diagenode s.a.
10.3.12. Active Motif, Inc.
10.3.13. Zymo Research Corporation
10.3.14. Thermo Fisher Scientific
10.3.15. Syndax
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes